Long-Term Assessment

Continued studies, reports and surveys

The assessment of our smoke-free products continues after the products are placed on the market. It consists of safety surveillance, cross-sectional surveys to monitor prevalence, and cohort studies to monitor the product’s effect on public health.


IQOS use overseas

Over 5 million adults smokers have already fully switched to IQOS as of July 2018. The chart below shows exclusive and predominant user shares among persons who purchased IQOS as of December 2017.

    Exclusive use
(≥95% IQOS)
    Predominant use
(70%-95% IQOS)